DB17409InvestigationalCell transplant therapies
KITE-585 is an autologous, fully-human anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell therapy. It is being investigated in the treatment of multiple myeloma.
- Code names
- KITE-585
What you can answer from here — as of September 25, 2025
Which companies are running trials of KITE-585, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account